1,124
Views
0
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability

Pages 1259-1268 | Received 13 May 2022, Accepted 10 Oct 2022, Published online: 26 Oct 2022